---
title: 'Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced
  Hematologic Malignant Neoplasms: A Meta-Analysis'
date: '2024-10-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39374017/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241007200555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: This meta-analysis found a low prevalence
  of ventricular arrhythmia, myocardial infarction, and cardiovascular death among
  CAR T-cell recipients over a short-term to midterm follow-up. Left ventricular dysfunction
  and supraventricular arrhythmia were the most commonly reported cardiovascular complications,
  suggesting that cardiovascular surveillance strategies should focus on decreases
  in ejection fraction and supraventricular ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: This meta-analysis found a low prevalence of ventricular arrhythmia, myocardial infarction, and cardiovascular death among CAR T-cell recipients over a short-term to midterm follow-up. Left ventricular dysfunction and supraventricular arrhythmia were the most commonly reported cardiovascular complications, suggesting that cardiovascular surveillance strategies should focus on decreases in ejection fraction and supraventricular ...